Titan Pharmaceuticals (NASDAQ:TTNP) Now Covered by StockNews.com

Stock analysts at StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Trading Down 0.3% Titan Pharmaceuticals stock opened at $4.34 on Tuesday. The company has a market […]

Leave a Reply

Your email address will not be published.

Previous post Pulmatrix (NASDAQ:PULM) Coverage Initiated at StockNews.com
Next post RGC Resources (NASDAQ:RGCO) Stock Rating Upgraded by StockNews.com